Sabra Healthcare REIT (NASDAQ:SBRA) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $18.67 and traded as high as $19.49. Sabra Healthcare REIT shares last traded at $19.05, with a volume of 2,397,113 shares traded.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. UBS Group started coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 price target for the company. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective for the company. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Saturday, January 3rd. Finally, National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research report on Friday, October 17th. Four analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT has an average rating of “Hold” and an average target price of $21.00.

Sabra Healthcare REIT Stock Performance

The firm has a market capitalization of $4.75 billion, a price-to-earnings ratio of 26.46, a price-to-earnings-growth ratio of 1.18 and a beta of 0.67. The firm’s 50-day moving average price is $19.02 and its two-hundred day moving average price is $18.67. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 166.67%.

Institutional Trading of Sabra Healthcare REIT

Hedge funds and other institutional investors have recently made changes to their positions in the business. Focus Partners Wealth lifted its position in Sabra Healthcare REIT by 11.4% during the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after buying an additional 2,375 shares in the last quarter. Strs Ohio bought a new position in shares of Sabra Healthcare REIT in the first quarter worth about $777,000. Voya Investment Management LLC grew its stake in shares of Sabra Healthcare REIT by 13.4% during the first quarter. Voya Investment Management LLC now owns 422,477 shares of the real estate investment trust’s stock valued at $7,381,000 after purchasing an additional 49,884 shares during the last quarter. Parallel Advisors LLC increased its stake in shares of Sabra Healthcare REIT by 7.0% in the 2nd quarter. Parallel Advisors LLC now owns 17,477 shares of the real estate investment trust’s stock valued at $322,000 after buying an additional 1,146 shares during the period. Finally, Financiere des Professionnels Fonds d investissement inc. bought a new position in Sabra Healthcare REIT in the second quarter valued at about $209,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.